Old Web
English
Sign In
Acemap
>
authorDetail
>
Suresh Kumar
Suresh Kumar
Madigan Army Medical Center
ARDS
Coronavirus disease 2019
Cytokine release syndrome
Cytokine
Phases of clinical research
2
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.
2021
Expert Opinion on Biological Therapy
Suresh Kumar
Rosemarie de' Souza
Milind Y Nadkar
Randeep Guleria
Anjan Trikha
Shashank R. Joshi
Subramanian Loganathan
Sivakumar Vaidyanathan
Ashwani Marwah
Sandeep N. Athalye
Show All
Source
Cite
Save
Citations (6)
A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
2020
medRxiv
Suresh Kumar
Rosemarie de' Souza
Milind Y Nadkar
Randeep Guleria
Anjan Trikha
Shashank R. Joshi
Subramanian Loganathan
Sivakumar Vaidyanathan
Ashwani Marwah
Sandeep N. Athalye
Show All
Source
Cite
Save
Citations (2)
1